Provention Bio stock has undergone multiple analysts rating changes in the recent past.  Provention Bio stock Target Raised by   Chardan Capital on 6/16/2020. In a note to investors, the firm issued a new target price of $40.00. The analysts previously had $30.00 target price. Chardan Capital’s price target would indicate a potential upside of 156.74% from the stock’s previous close.

Shares of Provention Bio traded up $0.85 on Tuesday, reaching $16.43. 2697819 shares of the stock traded hands, compared to its average volume of 696968. Shares of Provention Bio finished the day on up  at $16.43 on Tuesday. The firm’s 50 day moving average is $$12.36 and its 200 day moving average is $11.01.Provention Bio  has a 12 month low of $15.41 and a 12 month high of $18.50. While on yearly highs and lows, Provention Bio today has traded high as $16.94 and has touched $15.41 on the downward trend.

Provention Bio Earnings and What to expect: 

Provention Bio last announced its quarterly earnings results on May 7th, 2020. The reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by $0.01. Provention Bio has generated ($1.06) earnings per share over the last year. Provention Bio has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, August 4th, 2020 based off prior year’s report dates.

Earnings for Provention Bio are expected to grow in the coming year, from ($1.21) to ($1.13) per share. The P/E ratio of Provention Bio is -14.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Provention Bio is -14.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Provention Bio has a P/B Ratio of 9.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 14.40%
  • On 3/19/2020 Insider Jason Hoitt Buy 4,500 at average share price of $6.25 which equates to $28,125.00 in money value.
  • On 12/26/2019 COO Eleanor Ramos Buy 2,000 at average price of  $14.66 with total value of : Not Data Available
  • On 12/20/2019 CEO Ashleigh Palmer Buy 2,075 at average price of  $11.39 with total value of : $23,634.25
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Provention Bio

  • 6/16/2020 – Provention Bio had its price target raised by analysts at HC Wainwright from $20.00 to $26.00. They now have a “buy” rating on the stock.
  • 6/15/2020 – Provention Bio is now covered by analysts at Oppenheimer Holdings Inc.. They set a “buy” rating and a $29.00 price target on the stock.
  • 6/9/2020 – Provention Bio was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 6/6/2020 – Provention Bio was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating.
  • See More Analyst Rating at: RATING

Other rating updates by Chardan Capital: 

  • 6/12/2020 – Crispr Therapeutics had its “buy” rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock.
  • 6/12/2020 – Editas Medicine had its “buy” rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
  • 6/12/2020 – Marina Biotech had its “buy” rating re-affirmed by analysts at Chardan Capital. They now have a $84.00 price target on the stock.
  • 6/10/2020 – Axovant Gene Therapies had its “buy” rating re-affirmed by analysts at Chardan Capital. They now have a $15.00 price target on the stock.
  • See More Analyst Rating at: RATING

Provention Bio (NASDAQ:PRVB) Moving Average Technical Analysis

5 day Moving Average is $$14.82 And 5 day price change is $3.31 (25.23%)  with average volume for 5 day average is 1,703,959. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $13.87 and 20 day price change is $2.56 (18.46%) and average 20 day moving volume is 906,305. 50 day moving average is $12.36  and 50 day price change is $8.62 ( 110.37%)  and with average volume for 50 days is : 667,764. 200 day moving average is $11.01  and 200 day price change is $7.12 (76.48%)  and with average volume for 200 days is : 614,648.

See More Analyst Rating at: RATING



Source link